VIP and Huntington disease: The presence of VIP during in vitro activation/expansion of memory Th cells reduces the gene expression of not only cytokines, but also transcription factors and cytokine receptors related to the Th17 subset and the pathogenic Th17/1 and Th1 phenotypes, with a greater intensity in HD than in eRA patients (Fig. 4).